CAMP 10-Q: SEC filing
CAMP4 Therapeutics Corporation
Filed with the SEC on · accession 0001628280-26-071054
CAMP filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -0.5% by the first close after the filing.
Summary of the filing
CAMP4 Therapeutics Corporation filed its quarterly report on Form 10-Q for the period ending September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification.
Key details
How CAMP stock reacted
Close before
$3.74
Nov 4, 2026
First close after
-0.53%
$3.72
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CAMP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CAMP?
Click hereFrequently asked questions
What did CAMP file with the SEC on Nov 5, 2026?
CAMP filed a 10-Q (SEC filing). CAMP4 Therapeutics Corporation filed its quarterly report on Form 10-Q for the period ending September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CAMP stock react to this filing?
CAMP closed at $3.74 before the filing and $3.72 on Nov 5, 2026 (-0.53%).
Other CAMP SEC filings
Get alerts when CAMP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days